Recommended Momentum ‘How’ and ‘Why’: Costco Wholesale (NASDAQ:COST), Xcel Energy (NYSE:XEL)

Costco Wholesale Corporation (NASDAQ:COST) [Trend Analysis] knocking active thrust in leading trading session, shares a loss of -1.27% to 161.86 with around 2.22 Million shares have changed hands in this session. Costco Wholesale Corp. (COST) declared that its total comparable sales for month of January 2017 surged 7 percent, with a 6 percent increase in U.S., a 11 percent rise in Canada, and Other International comparable sales rose 4 percent.

Monthly total Comparable sales, excluding the impacts from changes in gasoline prices and foreign exchange, were up 5 percent, with a 5 percent rise in U.S., a 1 percent increase in Canada, and 8 percent rise in Other International comparable sales. Net sales were $9.08 billion for the month of January, the four weeks ended January 29, 2017, an increase of nine percent from $8.32 billion during the similar period last year. The stock is going forward its fifty-two week low with 17.48% and lagging behind from its 52-week high price with -4.26%.

Similar, the positive performance for the quarter recorded as 9.80% and for the year was 10.25%, while the YTD performance remained at 1.09%. COST has Average True Range for 14 days of 1.83.

Xcel Energy Inc. (NYSE:XEL) [Trend Analysis] retains strong position in active trade, as shares scoring -1.67% to $40.63 in active trade session, while looking at the shares volume, around 2.72 Million shares have changed hands in this session. Xcel Energy Inc. (XEL) declared that its Q4 net income of $227.5 million. On a per-share basis, the Minneapolis-based company said it had profit of 45 cents. The results beat Wall Street expectations.

The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of 44 cents per share. The utility posted revenue of $2.79 billion in the period. For the year, the company declared profit of $1.12 billion, or $2.21 per share. Revenue was declared as $11.11 billion. Xcel expects full-year earnings in the range of $2.25 to $2.35 per share.

The firm has institutional ownership of 71.50%, while insider ownership included 0.10%. XEL attains analyst recommendation of 5.00 with week’s performance of -0.34%. Investors looking further ahead will note that the Price to next year’s EPS is 5.18%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *